OrganiGram (CVE:OGI) received a C$9.00 price target from analysts at Raymond James in a research report issued on Wednesday, BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock.
A number of other equities research analysts also recently weighed in on the company. AltaCorp Capital dropped their target price on OrganiGram from C$13.15 to C$6.50 in a research report on Tuesday. Jefferies Financial Group upgraded OrganiGram from a “hold” rating to a “buy” rating and dropped their target price for the stock from C$10.50 to C$8.20 in a research report on Friday, October 11th. CIBC set a C$9.00 target price on OrganiGram and gave the stock an “outperform” rating in a research report on Tuesday, September 24th. Finally, Canaccord Genuity dropped their price objective on OrganiGram from C$8.50 to C$7.00 in a report on Wednesday. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. OrganiGram has an average rating of “Buy” and a consensus target price of C$8.60.
The company has a market capitalization of $661.23 million and a P/E ratio of 28.02. OrganiGram has a 52-week low of C$4.11 and a 52-week high of C$11.30. The company has a current ratio of 9.06, a quick ratio of 4.14 and a debt-to-equity ratio of 14.71. The business’s fifty day moving average price is C$6.22 and its two-hundred day moving average price is C$7.97.
OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders.
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.